Синтез и антибактериальная активность 11-0-(бензоксаборол-аминоалкилкарбамоил) производных макролидного антибиотика азитромицина
Аннотация
Об авторах
С. С. ПринцевскаяРоссия
А. М. Королев
Россия
Ю. Н. Лузиков
Россия
Е. П. Мирчинк
Россия
Е. Б. Исакова
Россия
А. Н. Тевяшова
Россия
Список литературы
1. Torssell K. Arylboronic acids. III. Bromination of Tolylboronic Acids According To Wohl-Ziegler. Ark Kemi 1957; 10: 507-511.
2. Zhang J, Zhu M., Lin Y., Zhou H. The Synthesis of Benzoxaboroles And Their Applications in Medicinal Chemistry. Sci China Chem 2013; 56: 1372-1381.
3. Xia Y., Cao K., Zhou Y, Alley M.R.K., Rock F., Mohan M., Meewana M., Baker S.J., Lux S., Ding C.Z., Jia G.F., Kullyb M., Plattner J.J. Synthesis And SARof Novel Benzoxaboroles As a New Class of /3-Lactamase Inhibitors. Bioorg Med Chem Lett 2011; 21: 2533-2536.
4. Li X.F., Zhang S.M., Zhang Y.K., Liu Y.D., Charles Z., Zhou Y., Plattner J.J., Baker S.J., Bu W., Liu L., Kazmierski W.M., Duan M.S., Grimes R.M., Wright L.L., Smith G.K., Jarvest R.L., Ji J.J., Cooper J.P., Tallant M.D., Crosby R.M., Creech K., Ni Z.J., Zou W.X., Wright J. Synthesis and SAR of Acyclic HCV NS3 Protease Inhibitors With Novel P4-Benzoxaborole Moieties. Bioorg Med Chem Lett 2011; 21: 2048-2054.
5. Akama T, Baker S.J., Zhang Y.K., Hernandez V., Zhou H.C., Sanders V., Freund Y., Kimura R., Maples K.R., Plattner J.J. Discovery and Structure-Activity Study of A Novel Benzoxaborole Anti-Inflammatory Agent (AN2728) For The Potential Topical Treatment of Psoriasis And Atopic Dermatitis. Bioorg Med Chem Lett 2009; 19: 2129-2132.
6. Printsevskaya S.S., Reznikova M.I., Korolev A.M., Lapa G.B., Olsufyeva E.N., Preobrazhenskaya M.N., Plattner J.J., Zhang Y.K. Synthesis And Study of Antibacterial Activities of Antibacterial Glycopeptides Antibiotics Conjugated With Benzoxaboroles. Future Med Chem 2013; 5: 641-652.
7. Qiao Z T., Wang Q., Zhang F.L., Wang Z.L., Bowling T., Nare B., Jacobs R.T., Zhang J., Ding D.Z., Liu Y.G., Zhou. H.C. Chalcone-Benzoxaborole Hybrid Molecules As Potent Antitrypanosomal Agents. J Med Chem 2012; 55: 3553-3557.
8. Tevyashova A.N., Korolev A.M., Trenin A.S., Dezhenkova L.G., Shtil A.A., Polshakov V.I., Savelyev O.Y., Olsufyeva E.N. New Conjugates of Polyene Macrolide Amphotericin B With Benzoxaboroles: Synthesis And Properties. J Antibiot (Tokyo) 2016; 69: 549-560.
9. Kapic S., Paljetak H.C., Alihodzic S., Antolovic R., Haber E.V., Jarvest R.L., Holmes D.J., Broskey J.P., Hunt E. 6-Alkylquinolone-3-Carboxylic Acid Tethered To Macrolides Synthesis And Antimicrobial Profile. Bioorg Med Chem.2010; 18: 6569-6577.
10. Skugor M.M., Stimac V., Palej I., Lugaric D., Paljetak H.C., Filic D., Modric M., Dilovic I., Gembarovski D., Mutak S., Haber V.E., Holmes D.J., Ivezic-Schoenfeld Z., Alihodzic S. Synthesis And Biological Activity of 4’’-O-Acyl Derivatives of 14- And 15-Membered Macrolides Linked to Ω-Quinolone-Carboxylic Unit. Bioorg Med Chem 2010; 18: 6547-6558.
11. Fajdetic A., Paljetak H.C., Lazarevski G., Hutinec A., Alihodzic S., Derek M., Stimac V., Andreotti D., Sunjic V., Berge J.M., Mutak S., Dumic M., Lociuro S., Holmes D.J., Marsic N., Haber V.E., Spaventi R. 4’’-O-(Ω-Quinolylamino-Alkylamino)Propionyl Derivatives of Selected Macrolides With The Activity Against The Key Erythromycin Resistant Respiratory Pathogens. Bioorg Med Chem 2010; 18: 6559-6568.
12. Jakopovic I.P., Kragol G., Forrest A.K., Frydrych C.S.V., Stimac V., Kapic S., Skugor M.M., Ilijas M, Paljetak H.C., Jelic D., Holmes D.J., Hickey D.M.B., Verbanac D., Haber V.E., Alihodzic S. Synthesis And Properties of Macrolones Characterized By Two Ether Bonds in The Linker. Bioorg Med Chem 2010; 18: 6578-6588.
13. Kapic S., Paljetak H.C., Jakopovic I.P., Fajdetic A., Ilija M., Stimac V., Brajsa K., Holmes D.J., Berge J., Alihodzic S. Synthesis of Macrolones With Central Piperazine Ring in The Linker And Its Influence on Antibacterial Activity. Bioorg Med Chem 2011; 19: 7281-7298.
14. Lapa G.B., Mirchink E.P., Isakova E.B., Preobrazhenskaya M.N. Two Approaches to The Use Of Benzo[C][1,2]oxaborles As Active Fragments For Synthetic Transformation of Clarithromycin. J Enzyme Inhibition Med Chem 2017; 32: 452-456.
15. Gaynor M., Mankin A.S. Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance. Curr Topics Med Chem 2003; 3: 949-961.
16. Li X., Ma S., Yan M., Wang Y., Ma S. Synthesis And Antibacterial Evaluation of Novel 11,4’’-Disubstituted Azithromycin Analogs With Greatly Improved Activity Against Erythromycin-Resistant Bacteria. Europ J Med Chem 2013; 59: 209-217.
17. NCCLS-The National Committee for Laboratory Standards. Performance standards for antimicrobial susceptibility testing; NCCLS document M100-S15, USA 2005.
18. Barber J. Assignments of The 13C And 1H NMR Spectra of Azithromycin In CDC13. Magnet Resonan Chem 1991; 29: 740-743.
19. Brennan R.J., Barber J. Full Assignments of The 13C And LH NMR Spectra of Azithromycin in Buffered D2O And DMSO-D6. Magnet Resonan Chem 1992; 30: 327-333.
Рецензия
Для цитирования:
Принцевская С.С., Королев А.М., Лузиков Ю.Н., Мирчинк Е.П., Исакова Е.Б., Тевяшова А.Н. Синтез и антибактериальная активность 11-0-(бензоксаборол-аминоалкилкарбамоил) производных макролидного антибиотика азитромицина. Антибиотики и Химиотерапия. 2018;63(1-2):3-7.
For citation:
Printsevskaya S.S., Korolev A.M., Luzikov Yu.N., Mirchink E.P., Isakova E.B., Tevyashova A.N. Synthesis and Antibacterial Activity of ll-O-(Benzoxaborole-Aminoalkylcarbamoyl) Derivatives of Macrolide Antibiotic Azithromycin. Antibiot Khimioter = Antibiotics and Chemotherapy. 2018;63(1-2):3-7. (In Russ.)